跳至主要内容
临床试验/IRCT2016010725892N1
IRCT2016010725892N1已完成未知

Effect of Adding Aspirin to Antipsychotic Treatment on Severity of Symptoms in Schizophrenic Patients

Isfahan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • The inclusion criteria were age of 18-65 years old; diagnosed with schizophrenia based on clinical interview and DSM-IV-TR; patients with 2 years of history since the onset of the disease. The exclusion criteria were unwillingness to participate in the study; failure to see doctor for follow-up for whatever reason; unstable medical illness and medical history; contraindications for use of aspirin, such as asthma or seasonal allergies, ulcers, kidney disease, active bleeding or clotting of blood disorders such as hemophilia or bleeding, gout, nasal polyps; chronic use of NSAID; concomitant use of corticosteroids for any reason and maternity.

排除标准

  • 未提供

研究者

相似试验